Loading…
Evonik is restructuring its Animal Nutrition business, separating amino acids and specialty nutrition into different operating models. The company plans €200 million in annual cost savings from 2025, including about 200 job cuts, and is investing in global hubs.
Cost cuts and hub investments may improve supply security for methionine, but the restructuring is unlikely to shift near-term prices on its own.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.